Abstract: There is provided a signal processing device including: a packet receiving means for receiving a packet from a transmitting communication device; and a packet processing means for transmitting the received packet received by the packet receiving means, simply as received or after processing by a packet converting means, to a receiving communication device that is a destination of the packet, wherein when a communication session between a first transmitting communication device and the receiving communication device is established and the session is shifted to have a connection between a second transmitting communication device and the receiving communication device, the packet converting means converts the received packet received from the second transmitting communication device so as to maintain a consecutiveness related to a content of packets to be transmitted to the receiving communication device.

Abstract: The present invention relates to a communications relay device placed between networks. The communications relay device includes a unit of translating a content of a call control packet flowing between the networks, a unit of storing translation information for translating a content of a data packet for each session, a unit of translating a data packet in accordance with the stored translation information, a unit of analyzing a content of a call control packet flowing between a first communication device placed in the first network and a communication device for call control and registering translation information, and a unit of associating two pieces of translation information generated based on call control packets relevant to a session between communication devices placed in the first network.

Abstract: There is provided a signal processing device including: a packet receiving means for receiving a packet from a transmitting communication device; and a packet processing means for transmitting the received packet received by the packet receiving means, simply as received or after processing by a packet converting means, to a receiving communication device that is a destination of the packet, wherein when a communication session between a first transmitting communication device and the receiving communication device is established and the session is shifted to have a connection between a second transmitting communication device and the receiving communication device, the packet converting means converts the received packet received from the second transmitting communication device so as to maintain a consecutiveness related to a content of packets to be transmitted to the receiving communication device.

Abstract: The present invention relates to a communications relay device placed between networks. The communications relay device includes a unit of translating a content of a call control packet flowing between the networks, a unit of storing translation information for translating a content of a data packet for each session, a unit of translating a data packet in accordance with the stored translation information, a unit of analyzing a content of a call control packet flowing between a first communication device placed in the first network and a communication device for call control and registering translation information, and a unit of associating two pieces of translation information generated based on call control packets relevant to a session between communication devices placed in the first network.

Abstract: An anti-Helicobacter pylori pharmaceutical composition containing a 1-hydroxy-3-methyl-quinolone derivative represented by the following formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient. Since it shows antibacterial action upon Helicobacter pylori, this invention is effective for the treatment or prevention of infection with Helicobacter pylori in human and infection with related bacteria belonging to the genus Helicobacter in animals. Also, the anti-Helicobacter pylori pharmaceutical composition of the present invention is useful for the prevention (including prevention of relapse) or treatment of diseases of the upper digestive organs, such as peptic ulcers (e.g., gastric and duodenal ulcers), inflammations (e.g., acute or chronic gastritis or duodenitis) and gastric cancer, as well as MALT (mucosa-associated lymphoid tissue) lymphoma or chronic heart diseases.

Abstract: A fluorophosphate optical glass having optical constants, i.e. a refractive index of 1.45 to 1.54 and an Abbe number of 75 to 90, preferably 75 to 89.5, useful as a lens for an optical instrument to obtain a good quality image, is provided, which has a chemical composition (% by mole) comprising:______________________________________ P.sub.2 O.sub.5 6.8-19.0% Al.sub.2 O.sub.3 1.5-6.0% BaO 0.3-6.6% AlF.sub.3 16.6-26.3% MgF.sub.2 2.5-19.0% CaF.sub.2 8.0-28.0% SrF.sub.2 9.7-35.0% BaF.sub.2 7.9-35.0% NaF 0.5-4.0% Gd.sub.2 O.sub.3 1.0-6.0% Y.sub.2 O.sub.3 0-3.5% La.sub.2 O.sub.3 0-3.5% Yb.sub.2 O.sub.3 0-3.5% sum of Gd.sub.2 O.sub.3, Y.sub.2 O.sub.3, La.sub.2 O.sub.3 and Yb.sub.2 O.sub.3 1.0-6.0% GdF.sub.3 0-2.0% CaO 0-3.5% SrO 0-3.5% ZnO 0-3.5% MgO 0-3.

Abstract: A fluorophosphate optical glass having optical constants, i.e. refractive index (nd) of 1.54 to 1.60 and Abbe number (.nu.d) of 68 to 75 and having abnormal partial dispersion represented by a relative partial dispersion of at least 0.537 is provided, which has a chemical composition (% by weight) comprising:______________________________________ Al(PO.sub.3).sub.3 15-32% Ba(PO.sub.3).sub.2 0-10% Sr(PO.sub.3).sub.2 0-10% Ca(PO.sub.3).sub.2 0-10% Mg(PO.sub.3).sub.2 0-10% sum of metaphosphates 20-32% BaF.sub.2 20-70% SrF.sub.2 5-40% CaF.sub.2 0-15% MgF.sub.2 0-10% AlF.sub.3 0-5% GdF.sub.3 0-5% sum of fluorides 55-75% Gd.sub.2 O.sub.3 5-22% La.sub.2 O.sub.3 0-7% Y.sub.2 O.sub.3 0-10% Yb.sub.2 O.sub.